Tylenol Extra Strength
- Product NDC
- 67751-167
- 11-digit product format
- 677510167
- Labeler code
- 67751
- Product ID
- 67751-167_2385e645-881c-5dd8-e063-6394a90adfab
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-09-22
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67751-167 | 67751-167-04 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 67751-167 | 67751-167-03 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-03 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-02 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-04 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-01 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-04 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-03 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-02 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-04 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-03 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-02 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-01 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-04 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-03 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-02 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 67751-167-03 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 67751-167-03 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 67751-167-03 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tylenol Extra Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86b6ac01-3866-4cd8-a1be-9babb6ff311b | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Indexing SPL | Related label |
|---|---|---|---|
| 67751-167-01 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2024-04-17 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
| 67751-167-04 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-01 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-04 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2020-01-31 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-167-01 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-01 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 4 in 1 POUCH | TABLET, FILM COATED | 4 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-03 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 2 | |
| 67751-167-03 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241004_86b6ac01-3866-4cd8-a1be-9babb6ff311b.zip |
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240418_65bf1556-f25a-9439-e053-2a91aa0a3194.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pediacare Childrens Acetaminophen Grape | ACETAMINOPHEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 596372c7-eca3-4527-8e22-ab0751e2526b | 2024-12-30 | Warnings | M013 |
| Bayer Genuine Aspirin | BAYER GENUINE ASPIRIN | Lil' Drug Store Products, Inc. | d17834d7-cb3e-6bf2-e053-2a95a90ae5c1 | 2024-12-30 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN 500 MG, FILM-COATED CAPLET | Lil' Drug Store Products, Inc. | e5fd2b46-683e-4cf5-e053-2995a90a5512 | 2024-12-30 | Warnings | M013 |
| Night Time Severe Cold and Cough Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Chain Drug Consortium, LLC | c8e9b57b-83e9-46c5-9791-02c4c2b94004 | 2024-12-29 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 1608b4f0-bf20-4024-b8f2-20a4df7a4b21 | 2024-12-26 | Warnings | M013 |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | f6a9ea44-08b8-4a33-bfbd-68cb2d852c39 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | cfc7eac3-35be-4002-b8ef-be1dfc8caf69 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | a3031139-4709-43f2-95a8-89840c595f7f | 2024-12-26 | Warnings | M013 |
| Acetaminophen 250mg Aspirin 250mg Caffeine 65mg | ACETAMINOPHEN 250MG ASPIRIN 250MG CAFFEINE 65MG | WALGREENS CO. | 98bb28ed-d146-ca3d-e053-2a95a90a9eaf | 2024-12-26 | Warnings | M013 |
| Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg | ACETAMINOPHEN 500MG CAFFEINE 60MG PYRILAMINE MALEATE 15MG | WALGREENS CO. | 982faa74-d498-cd1e-e053-2995a90afa1e | 2024-12-25 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 11bf6e1b-aed9-4f8f-9f03-ea911ae9f702 | 2024-12-23 | Warnings | M013 |
| Rugby Regular Strength Acetaminophen | ACETAMINOPHEN | RUGBY LABORATORIES | 295b0d00-4d4a-405f-9325-d01c5d4f3ed4 | 2024-12-20 | Warnings | M013 |
| Walgreens Pain Relief Powder | ASPIRIN AND CAFFEINE | Walgreens Co. | 61493d34-2432-4683-9b32-e1851a4337be | 2024-12-18 | Warnings | M013 |
| Reese Headache Powders | ASPIRIN AND CAFFEINE | Reese Pharmaceutical Co | 386f7a6c-4bfc-4140-a67b-07f6b520d58f | 2024-12-18 | Warnings | M013 |
| NobleAid PAIN RELIEVER | ASPIRIN | Noble Otc LLC | aa08e488-2f69-4d7e-86ba-ccfad563edcf | 2024-12-18 | Warnings | M013 |
| Dollar General Headache Powders | ASPIRIN AND CAFFEINE | Dolgencorp, LLC | 11b0271b-d65c-49c4-a081-d71044a0e04c | 2024-12-18 | Warnings | M013 |
| Family Wellness Pain Relief Powder | ASPIRIN AND CAFFEINE | Family Dollar Services Inc | b2e55de7-3c36-49cc-8f7f-1013fd1ec359 | 2024-12-18 | Warnings | M013 |
| Best Choice Pain Relief Powder | ASPIRIN AND CAFFEINE | Value Merch | a95b9b22-ea5c-4a02-b35d-c8ae1e117604 | 2024-12-18 | Warnings | M013 |
| Walmart Pain Relief Powder | ASPIRIN AND CAFFEINE | Walmart | c69aa61f-6a74-40a3-8737-195fa545e261 | 2024-12-18 | Warnings | M013 |
| Quality Choice Pain Relief Powder | ASPIRIN AND CAFFEINE | Chain Drug Marketing Association | 8e1f4057-4968-4523-9b3f-55aea421b674 | 2024-12-18 | Warnings | M013 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-167-01 | 67751016701 | 1 POUCH in 1 CARTON (67751-167-01) / 2 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-02 | 67751016702 | 1 POUCH in 1 CARTON (67751-167-02) / 4 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-03 | 67751016703 | 12 in 1 TRAY | Historical | |||||
| 67751-167-04 | 67751016704 | 12 POUCH in 1 TRAY (67751-167-04) > 1 TABLET, FILM COATED in 1 POUCH | 12 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |